Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-09

Clinical Trial Update: Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) [Phase 3]

View source ↗

Summary

Phase 3 trial updating efficacy and safety of SPL7013 Gel to prevent BV recurrence has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPL7013 Gel (SPL7013)

Snippet

Sponsor: Starpharma Pty Ltd | Conditions: Bacterial Vaginosis | Phase 3 | Status: COMPLETED | Results posted: 2019-07-09